Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Endo Pharma to pay US$ 23 mn to LecTec to settle patent litigation
Pharmabiz
Saturday, November 14, 2009 - 1:12pm
tags:
Endo, LecTec
Why the FDA Needs to Accept PhRMA's Social Proposal
Advertising Age
Saturday, November 14, 2009 - 1:05pm
tags:
PhRMA
Abbott: Brave or Stupid?
Motley Fool
Saturday, November 14, 2009 - 1:00pm
tags:
Abbott Laboratories
Questioning Pfizer's Integrity
Motley Fool
Saturday, November 14, 2009 - 12:58pm
tags:
Pfizer, Neurontin
Lilly Gets R&D Chief From Outside. Drugs to Follow?
Wall St. Journal
Saturday, November 14, 2009 - 12:52pm
tags:
Eli Lilly
Spectrum Pharmaceuticals, Inc.: Warming Up or Cooling Off?
Motley Fool
Saturday, November 14, 2009 - 12:51pm
tags:
Spectrum Pharmaceuticals
Merck: Both Sides Now
CNBC
Saturday, November 14, 2009 - 12:46pm
tags:
Merck, Arbiter 6
Genzyme Issues Letters to U.S. Healthcare Providers
Yahoo/BusinessWire
Saturday, November 14, 2009 - 12:44pm
tags:
Genzyme
Law Firms Going After Hemispherx
Seeking Alpha
Saturday, November 14, 2009 - 12:42pm
tags:
Hemispherx
Trimeris profit sliced in half
bizjournals.com
Saturday, November 14, 2009 - 12:41pm
tags:
Trimeris
Lexicon says IBS drug met mid-stage study goal
Yahoo/AP
Saturday, November 14, 2009 - 12:37pm
tags:
IBS, irritable bowel syndrome, Lexicon Pharmaceuticals
Gilead Awaits Committee Outcome
Yahoo/Zacks.com
Friday, November 13, 2009 - 10:38am
tags:
Gilead Sciences, FDA, aztreonam
Another Win for Mylan
Yahoo/Zacks.com
Friday, November 13, 2009 - 10:36am
tags:
Mylan, Pfizer, Matrixx, Bristol-Myers Squibb, FDA, Takeda
Options Boil on Biotech Buyout Rumors - Cubist
CNBC
Friday, November 13, 2009 - 9:56am
tags:
options, biotech, Cubist Pharmaceuticals
House Bill Wants Pharma To Disclose CME Funding
Pharmalot
Friday, November 13, 2009 - 9:55am
tags:
healthcare reform, healthcare bill, CME
GSK's Witty doesn't anticipate dip in profit margins
Fierce Pharma
Friday, November 13, 2009 - 9:54am
tags:
GSK, Pharma CEOs, Andrew Witty
The Next Vytorin Study: Why Is Everybody So Worked Up?
WSJ Online
Friday, November 13, 2009 - 9:51am
tags:
Vytorin, cholesterol, Niaspan
Piper Jaffray Sees Pharma M&A Activity Continuing
Yahoo/Wall Street Transcript
Friday, November 13, 2009 - 9:50am
tags:
M&A, Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb
Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching
BNET Pharma
Friday, November 13, 2009 - 8:54am
tags:
Biogen Idec, social media, FDA, Tysabri, MS, multiple sclerosis
Myriad Pharma posts smaller 1Q loss after spinoff
Yahoo/AP
Friday, November 13, 2009 - 8:40am
tags:
Myriad Genetics, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.